CytomX Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
CytomX Therapeutics, Inc. (CTMX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 377.25 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-06
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 106.75K shares, a 83.51% decline year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 270.50K shares, a 55.53% decline year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 28.35K shares, a 12.25% increase year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 903.24K shares, a 1748.03% increase year-over-year.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 2.19M shares, a 239.50% increase from fiscal 2024.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 644.20K shares, a 71.52% decline from fiscal 2023.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 2.26M shares, a 40.33% decline from fiscal 2022.
- CytomX Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 3.79M shares, a 11.91% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 106.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | 377.25K shares 10-Q · filed 2026-08-06 | 405.60K shares derived: sum of 3 quarters · filed 2026-08-06 | 1.31M shares derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | 270.50K shares 10-Q · filed 2026-05-07 | 298.85K shares derived: sum of 2 quarters · filed 2026-05-07 | 1.20M shares derived: sum of 3 quarters · filed 2026-05-07 | 1.85M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 28.35K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | 931.60K shares derived: sum of 2 quarters · filed 2026-03-16 | 1.58M shares derived: sum of 3 quarters · filed 2026-03-16 | 2.19M shares 10-K · filed 2026-03-16 |
| 2025-09-30 | 903.24K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | 1.55M shares derived: sum of 2 quarters · filed 2025-11-06 | 2.16M shares 10-Q · filed 2025-11-06 | 2.18M shares derived: sum of 4 quarters · filed 2025-11-06 |
| 2025-06-30 | 647.17K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | 1.26M shares 10-Q · filed 2025-08-07 | 1.28M shares derived: sum of 3 quarters · filed 2025-08-07 | 1.33M shares derived: sum of 4 quarters · filed 2025-08-07 |
| 2025-03-31 | 608.31K shares 10-Q · filed 2025-05-12 | 633.57K shares derived: sum of 2 quarters · filed 2025-05-12 | 682.44K shares derived: sum of 3 quarters · filed 2025-05-12 | 949.17K shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 25.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 74.14K shares derived: sum of 2 quarters · filed 2025-03-06 | 340.86K shares derived: sum of 3 quarters · filed 2025-03-06 | 644.20K shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 48.88K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | 315.60K shares derived: sum of 2 quarters · filed 2024-11-07 | 618.94K shares 10-Q · filed 2024-11-07 | 1.12M shares derived: sum of 4 quarters · filed 2024-11-07 |
| 2024-06-30 | 266.72K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | 570.06K shares 10-Q · filed 2024-08-08 | 1.07M shares derived: sum of 3 quarters · filed 2024-08-08 | 1.98M shares derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | 303.34K shares 10-Q · filed 2024-05-08 | 804.60K shares derived: sum of 2 quarters · filed 2024-05-08 | 1.71M shares derived: sum of 3 quarters · filed 2024-05-08 | 2.26M shares derived: sum of 4 quarters · filed 2024-05-08 |
| 2023-12-31 | 501.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-11 | 1.41M shares derived: sum of 2 quarters · filed 2024-03-11 | 1.96M shares derived: sum of 3 quarters · filed 2024-03-11 | 2.26M shares 10-K · filed 2024-03-11 |
| 2023-09-30 | 909.49K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | 1.45M shares derived: sum of 2 quarters · filed 2023-11-07 | 1.76M shares 10-Q · filed 2023-11-07 | 2.76M shares derived: sum of 4 quarters · filed 2023-11-07 |
| 2023-06-30 | 544.34K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 851.51K shares 10-Q · filed 2023-08-08 | 1.85M shares derived: sum of 3 quarters · filed 2023-08-08 | 3.57M shares derived: sum of 4 quarters · filed 2023-08-08 |
| 2023-03-31 | 307.18K shares 10-Q · filed 2023-05-09 | 1.31M shares derived: sum of 2 quarters · filed 2023-05-09 | 3.02M shares derived: sum of 3 quarters · filed 2023-05-09 | 3.67M shares derived: sum of 4 quarters · filed 2023-05-09 |
| 2022-12-31 | 998.95K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | 2.71M shares derived: sum of 2 quarters · filed 2023-03-27 | 3.36M shares derived: sum of 3 quarters · filed 2023-03-27 | 3.79M shares 10-K · filed 2023-03-27 |
| 2022-09-30 | 1.71M shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 2.36M shares derived: sum of 2 quarters · filed 2022-11-08 | 2.79M shares 10-Q · filed 2022-11-08 | 3.13M shares derived: sum of 4 quarters · filed 2023-03-27 |
| 2022-06-30 | 644.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | 1.08M shares 10-Q · filed 2022-08-04 | 1.42M shares derived: sum of 3 quarters · filed 2023-03-27 | 2.31M shares derived: sum of 4 quarters · filed 2023-03-27 |
| 2022-03-31 | 432.43K shares 10-Q · filed 2022-05-05 | 773.06K shares derived: sum of 2 quarters · filed 2023-03-27 | 1.66M shares derived: sum of 3 quarters · filed 2023-03-27 | 2.29M shares derived: sum of 4 quarters · filed 2023-03-27 |
| 2021-12-31 | 340.63K shares derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-27 | 1.23M shares derived: sum of 2 quarters · filed 2023-03-27 | 1.85M shares derived: sum of 3 quarters · filed 2023-03-27 | 3.39M shares 10-K/A · filed 2023-03-27 |
| 2021-09-30 | 891.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | 1.51M shares derived: sum of 2 quarters · filed 2021-11-04 | 3.05M shares 10-Q · filed 2021-11-04 | 3.52M shares derived: sum of 4 quarters · filed 2021-11-04 |
| 2021-06-30 | 620.59K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | 2.16M shares 10-Q · filed 2021-08-05 | 2.63M shares derived: sum of 3 quarters · filed 2021-08-05 | 3.29M shares derived: sum of 4 quarters · filed 2021-08-05 |
| 2021-03-31 | 1.54M shares 10-Q · filed 2021-05-06 | 2.01M shares derived: sum of 2 quarters · filed 2021-05-06 | 2.67M shares derived: sum of 3 quarters · filed 2021-05-06 | 3.26M shares derived: sum of 4 quarters · filed 2021-05-06 |
| 2020-12-31 | 471.90K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | 1.13M shares derived: sum of 2 quarters · filed 2021-02-24 | 1.72M shares derived: sum of 3 quarters · filed 2021-02-24 | 2.16M shares 10-K · filed 2021-02-24 |
| 2020-09-30 | 662.86K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | 1.25M shares derived: sum of 2 quarters · filed 2020-11-05 | 1.69M shares 10-Q · filed 2020-11-05 | 2.05M shares derived: sum of 4 quarters · filed 2020-11-05 |
| 2020-06-30 | 589.13K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | 1.03M shares 10-Q · filed 2020-08-06 | 1.38M shares derived: sum of 3 quarters · filed 2020-08-06 | 1.75M shares derived: sum of 4 quarters · filed 2020-08-06 |
| 2020-03-31 | 436.96K shares 10-Q · filed 2020-05-07 | 795.28K shares derived: sum of 2 quarters · filed 2020-05-07 | 1.17M shares derived: sum of 3 quarters · filed 2020-05-07 | 1.37M shares derived: sum of 4 quarters · filed 2020-05-07 |
| 2019-12-31 | 358.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 728.50K shares derived: sum of 2 quarters · filed 2020-02-27 | 929.33K shares derived: sum of 3 quarters · filed 2020-02-27 | 990.36K shares 10-K · filed 2020-02-27 |
| 2019-09-30 | 370.18K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-07 | 571.01K shares derived: sum of 2 quarters · filed 2019-11-07 | 632.04K shares 10-Q · filed 2019-11-07 | 673.98K shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-06-30 | 200.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | 261.86K shares 10-Q · filed 2019-08-07 | 303.80K shares derived: sum of 3 quarters · filed 2020-02-27 | 327.91K shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2019-03-31 | 61.02K shares 10-Q · filed 2019-05-09 | 102.96K shares derived: sum of 2 quarters · filed 2020-02-27 | 127.08K shares derived: sum of 3 quarters · filed 2020-02-27 | 180.96K shares derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-12-31 | 41.94K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | 66.05K shares derived: sum of 2 quarters · filed 2020-02-27 | 119.94K shares derived: sum of 3 quarters · filed 2020-02-27 | 153.70K shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 24.11K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | 78.00K shares derived: sum of 2 quarters · filed 2018-11-06 | 111.76K shares 10-Q · filed 2018-11-06 | |
| 2018-06-30 | 53.89K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | 87.65K shares 10-Q · filed 2018-08-08 | ||
| 2018-03-31 | 33.76K shares 10-Q · filed 2018-05-09 | |||
| 2017-12-31 | 1.03M shares 10-K · filed 2020-02-27 | |||
| 2016-12-31 | 54.16K shares 10-K · filed 2019-02-27 | |||
| 2016-03-31 | 8.74K shares 10-Q · filed 2016-05-06 | 8.73K shares derived: sum of 2 quarters · filed 2018-03-07 | ||
| 2015-12-31 | -11.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | 12.90K shares 10-K · filed 2018-03-07 | ||
| 2015-09-30 | 12.91K shares 10-Q · filed 2015-11-23 | |||
| 2014-12-31 | 230.17K shares 10-K · filed 2017-03-02 | |||
| 2013-12-31 | 7.16K shares 10-K · filed 2016-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Monopar Therapeutics (MNPR) | United States | $0.598B | -34.82 |
| Altimmune, Inc. (ALT) | United States | $0.593B | -6.43 |
| CorMedix Inc. (CRMD) | United States | $0.605B | 3.25 |
| Aquestive Therapeutics, Inc. (AQST) | United States | $0.606B | -6.67 |
| IMPACT BIOMEDICAL INC. (IBO) | United States | $0.611B | 66.47 |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |
| Neurogene Inc. (NGNE) | $0.625B | -4.46 | |
| Shattuck Labs, Inc. (STTK) | United States | $0.634B | -13.30 |
| BlossomHill Therapeutics, Inc. (BLSM) | United States | $0.647B | |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B |